Andag, Elliana .
HRN: 23-60-27 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/28/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/28/2023
09/04/2023
IV
80mg
TID
AGE W/ Mod. DehydratIon
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes